Guggenheim Capital LLC Canopy Growth Corp Transaction History

Guggenheim Capital LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$22.12 - $32.06 $445,364 - $645,496	-20,134 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$14.05 - $29.0 $3,076 - $6,351	219 Added 1.1%	20,134 $496,000
Q3 2020 Nov 13, 2020	SELL	$14.17 - $19.48 $134,544 - $184,962	-9,495 Reduced 32.28%	19,915 $285,000
Q2 2020 Aug 14, 2020	BUY	$13.25 - $21.72 $239,440 - $392,502	18,071 Added 159.37%	29,410 $475,000
Q1 2020 Jun 02, 2020	SELL	$9.73 - $24.9 $71,457 - $182,865	-7,344 Reduced 39.31%	11,339 $164,000
Q4 2019 Feb 14, 2020	BUY	$14.22 - $23.38 $98,715 - $162,303	6,942 Added 59.13%	18,683 $394,000
Q3 2019 Nov 14, 2019	BUY	$22.93 - $41.06 $1,077 - $1,929	47 Added 0.4%	11,741 $269,000
Q2 2019 Aug 14, 2019	SELL	$38.73 - $52.03 $222,155 - $298,444	-5,736 Reduced 32.91%	11,694 $471,000
Q1 2019 May 15, 2019	SELL	$28.11 - $50.77 $229,096 - $413,775	-8,150 Reduced 31.86%	17,430 $756,000
Q4 2018 Feb 14, 2019	BUY	$26.22 - $56.89 $670,707 - $1.46 Million	25,580 New	25,580 $687,000

8.28M

400

Ticker CGC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 480,284,000
Market Cap $2.31B
Description
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include d...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.